Skip to content
The Biotechnology Innovation Organization (BIO) filed an amicus brief opposing the Federal Trade Commission (FTC) lawsuit to block Amgen’s acquisition of Horizon, arguing that […]
BIO to file amicus brief opposing FTC interference in vital biotech merger activity Read More »
Imagine if you are diagnosed with cancer and now your treatment is delayed because you are denied immediate access to the medications you need.
Rising denials by health insurance plans are harming the patients they ‘serve’ Read More »
Respiratory syncytial virus, or RSV, innovations are big news this year—and for good reason. The biotech industry has finally cracked the code for treating
Codagenix Q&A: Diversifying vaccination options for patients Read More »
Childhood vaccination rates get a lot of attention, but it’s equally important to work on adult vaccination rates, too. “Right now, as a number
National Immunization Awareness Month: A conversation with GSK on adult vaccine access Read More »
Voters hold a favorable opinion of biotechnology and support streamlined government regulatory processes to allow faster approval of biotech innovations in agriculture, according to
In the latest bioscience victory over viruses, the Food and Drug Administration (FDA) on July 17 gave the first approval to a monoclonal antibody
FDA approves monoclonal antibody to protect infants from RSV Read More »
With so many life-science advances starting on the farm, the 2023 Farm Bill, which sets U.S. agriculture policy for the next five years, is
Why the 2023 Farm Bill matters to biotech Read More »
In the vaccine delivery industry, the need for disruption is clear. Today, more than 1.5 million people globally die each year from diseases for
Why a vaccine patch could be a game changer Read More »
Partnership has been the key to developing and delivering many of today’s most important medicines to patients. From the rapid development of COVID-19 vaccines
Lessons from COVID, the Inflation Reduction Act (IRA), drug prices, drug shortages, Accelerated Approval and a lawsuit seeking to block use of an approved
FDA Commissioner Califf on COVID lessons, Accelerated Approval, and more Read More »
